184 related articles for article (PubMed ID: 15776776)
1. Review of cyclosporine immunosuppressive safety data in dermatology patients after two decades of use.
Behnam SM; Behnam SE; Koo JY
J Drugs Dermatol; 2005; 4(2):189-94. PubMed ID: 15776776
[TBL] [Abstract][Full Text] [Related]
2. Early and explosive development of nodular basal cell carcinoma and multiple keratoacanthomas in psoriasis patients treated with cyclosporine.
Lain EL; Markus RF
J Drugs Dermatol; 2004; 3(6):680-2. PubMed ID: 15624753
[TBL] [Abstract][Full Text] [Related]
3. Long-term follow-up of cancer risk in patients treated with short-term cyclosporine.
Väkevä L; Reitamo S; Pukkala E; Sarna S; Ranki A
Acta Derm Venereol; 2008; 88(2):117-20. PubMed ID: 18311436
[TBL] [Abstract][Full Text] [Related]
4. The use of ciclosporin in psoriasis: a clinical review.
Ho VC
Br J Dermatol; 2004 May; 150 Suppl 67():1-10. PubMed ID: 15115440
[TBL] [Abstract][Full Text] [Related]
5. Cyclosporine and skin cancer: an international dermatologic perspective over 25 years of experience. A comprehensive review and pursuit to define safe use of cyclosporine in dermatology.
Muellenhoff MW; Koo JY
J Dermatolog Treat; 2012 Aug; 23(4):290-304. PubMed ID: 21936704
[TBL] [Abstract][Full Text] [Related]
6. Squamous-cell cancer of the skin in patients given PUVA and ciclosporin: nested cohort crossover study.
Marcil I; Stern RS
Lancet; 2001 Sep; 358(9287):1042-5. PubMed ID: 11589933
[TBL] [Abstract][Full Text] [Related]
7. Long-term safety of cyclosporine in the treatment of psoriasis.
Grossman RM; Chevret S; Abi-Rached J; Blanchet F; Dubertret L
Arch Dermatol; 1996 Jun; 132(6):623-9. PubMed ID: 8651712
[TBL] [Abstract][Full Text] [Related]
8. Multiple squamous cell carcinomas in a psoriatic patient following high-dose photochemotherapy and cyclosporin treatment: response to long-term acitretin maintenance.
van de Kerkhof PC; de Rooij MJ
Br J Dermatol; 1997 Feb; 136(2):275-8. PubMed ID: 9068750
[TBL] [Abstract][Full Text] [Related]
9. Cyclosporine: what clinicians need to know.
Koo J; Lee J
Dermatol Clin; 1995 Oct; 13(4):897-907. PubMed ID: 8785893
[TBL] [Abstract][Full Text] [Related]
10. The risk of melanoma in association with long-term exposure to PUVA.
Stern RS;
J Am Acad Dermatol; 2001 May; 44(5):755-61. PubMed ID: 11312420
[TBL] [Abstract][Full Text] [Related]
11. Immunosuppressive agents in dermatology.
Ho VC; Zloty DM
Dermatol Clin; 1993 Jan; 11(1):73-85. PubMed ID: 8435920
[TBL] [Abstract][Full Text] [Related]
12. Traditional therapies in the management of moderate to severe chronic plaque psoriasis: an assessment of the benefits and risks.
Naldi L; Griffiths CE
Br J Dermatol; 2005 Apr; 152(4):597-615. PubMed ID: 15840088
[TBL] [Abstract][Full Text] [Related]
13. Exacerbation of paranoid schizophrenia in a psoriatic patient after treatment with cyclosporine A, but not with etanercept.
Di Nuzzo S; Zanni M; De Panfilis G
J Drugs Dermatol; 2007 Oct; 6(10):1046-7. PubMed ID: 17966184
[TBL] [Abstract][Full Text] [Related]
14. A rare case of non-Hodgkins B-cell lymphoma in a psoriatic patient: a case report and literature review.
Gattu S; Becker EM; Koo JY
J Drugs Dermatol; 2010 Oct; 9(10):1277-81. PubMed ID: 20941955
[TBL] [Abstract][Full Text] [Related]
15. Infliximab for severe, treatment-resistant psoriasis: a prospective, open-label study.
Smith CH; Jackson K; Bashir SJ; Perez A; Chew AL; Powell AM; Wain M; Barker JN
Br J Dermatol; 2006 Jul; 155(1):160-9. PubMed ID: 16792769
[TBL] [Abstract][Full Text] [Related]
16. Two cases of chronic lymphoproliferative disorders in psoriatic patients treated with cyclosporine: hairy cell leukemia and Waldenstrom macroglobulinemia.
Fozza C; Dore F; Bonfigli S; Podda L; Longinotti M
Eur J Dermatol; 2005; 15(4):271-3. PubMed ID: 16048757
[TBL] [Abstract][Full Text] [Related]
17. Prolonged cyclosporine treatment of severe or recalcitrant psoriasis: descriptive study in a series of 20 patients.
Borghi A; Corazza M; Mantovani L; Bertoldi AM; Giari S; Virgili A
Int J Dermatol; 2012 Dec; 51(12):1512-6. PubMed ID: 23171021
[TBL] [Abstract][Full Text] [Related]
18. Clinical experience with the use of cyclosporin A in psoriasis. Results of a retrospective study.
Ojeda R; Sánchez Regaña M; Massana J; Oliete R; Umbert P
J Dermatolog Treat; 2005; 16(4):238-41. PubMed ID: 16249146
[TBL] [Abstract][Full Text] [Related]
19. Lymphoma risk in psoriasis: results of the PUVA follow-up study.
Stern RS
Arch Dermatol; 2006 Sep; 142(9):1132-5. PubMed ID: 16983000
[TBL] [Abstract][Full Text] [Related]
20. [Cyclosporine in the treatment of psoriasis].
Bjerke JR
Tidsskr Nor Laegeforen; 1992 Sep; 112(22):2863-5. PubMed ID: 1412327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
